Empirical Finance LLC Reduces Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Empirical Finance LLC lowered its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 13,095 shares of the company’s stock after selling 523 shares during the quarter. Empirical Finance LLC’s holdings in GE HealthCare Technologies were worth $1,020,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the stock. Pathway Financial Advisers LLC bought a new position in GE HealthCare Technologies in the first quarter worth $25,000. BNP Paribas bought a new position in shares of GE HealthCare Technologies in the 1st quarter worth about $30,000. Rise Advisors LLC increased its stake in shares of GE HealthCare Technologies by 241.4% in the 1st quarter. Rise Advisors LLC now owns 338 shares of the company’s stock worth $31,000 after acquiring an additional 239 shares in the last quarter. Riverview Trust Co purchased a new position in GE HealthCare Technologies during the 1st quarter valued at about $31,000. Finally, Annapolis Financial Services LLC boosted its stake in GE HealthCare Technologies by 171.9% during the first quarter. Annapolis Financial Services LLC now owns 348 shares of the company’s stock worth $32,000 after acquiring an additional 220 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, CEO Thomas J. Westrick sold 2,750 shares of the stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the transaction, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at approximately $1,414,377.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.27% of the stock is currently owned by insiders.

GE HealthCare Technologies Stock Up 0.9 %

GEHC stock opened at $84.82 on Friday. The stock has a market capitalization of $38.72 billion, a P/E ratio of 24.80, a P/E/G ratio of 3.00 and a beta of 1.17. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50. The business has a fifty day moving average price of $81.35 and a 200-day moving average price of $83.49.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. The business had revenue of $4.84 billion during the quarter, compared to analyst estimates of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. GE HealthCare Technologies’s revenue was up .5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.92 EPS. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were issued a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 0.14%. The ex-dividend date was Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on GEHC shares. The Goldman Sachs Group started coverage on shares of GE HealthCare Technologies in a research note on Thursday, May 30th. They set a “neutral” rating and a $87.00 target price for the company. Stifel Nicolaus began coverage on GE HealthCare Technologies in a research note on Tuesday, August 6th. They set a “buy” rating and a $100.00 price objective for the company. Finally, Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Five analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $95.00.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.